CI
CONE

Cigna Investments’s CyrusOne Inc Common Stock CONE Stock Holding History

Cigna Investments’s Portfolio CONE Stock Details CONE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,956
Closed -$265K – 676
2021
Q4 		$265K Sell
2,956
-750
-20% -$63.7K 0.02% 548
2021
Q3 		$287K Sell
3,706
-50
-1% -$3.76K 0.02% 570
2021
Q2 		$268K Sell
3,756
-500
-12% -$36.4K 0.02% 617
2021
Q1 		$288K Buy
4,256
+119
+3% +$8.26K 0.02% 609
2020
Q4 		$302K Buy
4,137
+488
+13% +$35.4K 0.02% 550
2020
Q3 		$256K Buy
3,649
+31
+0.9% +$2.43K 0.02% 526
2020
Q2 		$264K Buy
+3,618
New +$258K 0.02% 593
2019
Q4 		– Sell
-3,259
Closed -$232K – 680
2019
Q3 		$232K Buy
+3,259
New +$218K 0.02% 602

Other funds holding CONE

JCM
Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return
KA
Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Cigna Investments's CONE Position: Q1 2022 in Review

Cigna Investments sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 2,956 shares — an estimated $265K sold.

Cigna Investments first reported a position in CONE in Q3 2019 and held it in 8 quarters. The position peaked at $302K in Q4 2020. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Cigna Investments reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Cigna Investments sold 2,956 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $265K.
  • Cigna Investments first reported a position in CyrusOne Inc Common Stock in Q3 2019 and held it in 8 quarters.
  • Cigna Investments's CyrusOne Inc Common Stock position peaked at $302K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Cigna Investments's 13F filing for Q1 2022, filed 13 May 2022.